ACL : NYSE
Industry: Medical Supplies

COMPANY PROFILE

Company Details

Alcon Incorporated. The Group's principal activity is to develop, manufacture and market Pharmaceutical, Surgical Equipment and devices, Contact Lens and other vision care products. The Group's products treat eye diseases and disorders and general functions of the human eye. The Group operates through three segments namely: Surgical Equipment, ... More
Shares Outstanding 304.7M
Institutional Ownership 20.88%
Market Cap 44.9B
Last Stock Split None None
Cary R. Rayment Corporate Officer Address: Boesch 69,6331 Huenenberg  www.alcon.com

Investment Ratings

ACL Highlights

First Call expects 1.51 EPS for next quarter.
The current Price Target for ACL is $158.55.


COMPANY PERFORMANCE

Pricing Momentum
147.45
Last
2.19+1.51%
Today’s Change
144.90
Today’s Open
$147.90
Day High
$144.90
Day Low
793,731
Volume 
Quotes delayed by at least 20 minutes

Growth Rates

Earnings per Share

Revenue

Dividend


ACL  IndustryMouse over chart for more details

Loading...
Loading...